Trial Profile
A study to evaluate the medication adherence of blonanserin in chronic schizophrenic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Blonanserin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 20 Dec 2015 New trial record